BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$1.00
+0.00 (+0.02%)
As of Jun 25, 5:25 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +4,355.6% upside
Low Target $28.75
Average Target $44.56
High Target $50.07
Current Price $1.00
Current
$1.00
Target
$44.56
$28.75 $44.56 avg $50.07
Scenario Analysis
Bear Case
$28.75
2,774.7%
Low target
Base Case
$44.56
+4,355.6%
Avg target
Bull Case
$50.07
+4,906.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.19
-16.0% from high
52-Week Low
$0.56
+80.2% from low
Target vs 52W High
$44.56
+3,644.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%